chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The day after vaccination date patient began to have increased SOB and a headache (Pain Score of 6).  Spouse checked BP which was WNL for patient.  O2 sat was as low as 88% on room air.  Patient then applied O2 at 2LPM via nasal cannula.  O2 sats have maintained in the low 90's with home intermittent/on demand O2 in place.  Has required O2 24/7 since day after vaccination.  Headache has remained persistent with a pain score of 6 - unrelieved with routine scheduled pain medication, along with taking PRN Tylenol and Ibuprofen.  Patient verbalizes more fatigue than usual for himself.  Has had decreased appetite.
Band Aids were placed at each injection site.  Child removed bandage from HepA site immediately.  The three other sites developed a localized red rash in minutes.  All Band Aids were removed at that point & rash improved.
Patient received vaccine in clinic. waited 10 min in exam room. After leaving exam room patient felt dizzy. While speaking to medical staff patient passed out, she was caught by mom and staff and laid to the ground. Doctor was called. taken back to room and examined by doctor. Patient was cleared to leave after feeling better. As per patient and parent, patient was fasting before appt.
The incorrect shot was given to the patient. She received the monovalent pfizer vaccine instead of the intended bivalent pfizer booster.
vaccine was given at another facility and they do not have the information the day after receiving vaccine patient had pain in the contralateral arm and to a lesser extent in the same arm with weakness in the contralateral arm and muscle pain in both arms she has no fever no chills no other joint pains the pain is been unchanged for approximately 3 weeks she has no pain in her legs examination except for pain weakness is normal
Patient experienced redness/swelling/tendernous at the site of injection. She had flu like symptoms with a fever of 100.8, along with hallucinations that her skin was popping out of her arms on the injected site
puffy face; tender/itchy skin and rash to face, anterior arms; low grade fever;  Treated with benedryl
Shingles vaccination began as a round circle, red in color, and enlarged as the weekend passed.  Injection site sore. May 3rd, 2010 area has begun to shrink in size, but still feels bruised.
This spontaneous report was received from a medical assistant referring to an unspecified number of patients of unspecified gender and age. Information regarding the patients' pertinent medical history, drug reactions or allergies and concomitant therapy was not provided. On unknown dates, the unspecified number of improperly stored doses of VAQTA single dose, lot# N005274, expiration date 03-APR-2018 (route of administration and anatomical location were not reported), were administered to the patients. No adverse effects have been reported. The doses were stored in a temperature of 30 degrees Fahrenheit for 2 hours and 15 minutes. Data logger was involved. There was no previous temperature excursion reported. This is one of several reports from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1708USA005633: US-009507513-1708USA005632:
Anxiety; lot number stamped on vaccination card doesnot exist on Moderna Vaccine Tracker; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety) and SUSPECTED COUNTERFEIT PRODUCT (lot number stamped on vaccination card doesnot exist on Moderna Vaccine Tracker) in an elderly patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032K20A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced SUSPECTED COUNTERFEIT PRODUCT (lot number stamped on vaccination card doesnot exist on Moderna Vaccine Tracker). On an unknown date, the patient experienced ANXIETY (Anxiety). On 27-Jan-2021, SUSPECTED COUNTERFEIT PRODUCT (lot number stamped on vaccination card doesnot exist on Moderna Vaccine Tracker) had resolved. At the time of the report, ANXIETY (Anxiety) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
pt began approx 2 PM 15JAN93 w/unusual high pitched crying;  notify clinic & contact MD;
Red eyes, sore throat, throat tightness, tachycardia lasting 10-15 min treated with BENADRYL, ALLEGRA with resolution.
Nosebleed occurring for about 5 minutes twice since receiving the immunization. Has never had a nosebleed prior to receiving the COVID-19 Janssen Vaccine.
Patient reported to the office for his 2nd booster dose of COVID-19. He reported his prior doses had been given. When reviewed on the phone, it was explained the 2nd booster needed to be 4 months after first booster. He said it would be but after administering the booster dose. He reported the first booster was given in early January, which made only 3 months between doses.  Vaccination records could not be confirmed, because vaccines were given out of the country.
At 8:00 pm after receiving the vaccine at 3:00 pm I started with chills.  Went to bed to try to sleep and rest.  Then this tingling feeling started.  It would happen at different places through out my body.  It would be in my arms, hands, chest, head, legs, feet, side or everywhere.  Then it would be in just one area for a period of time.  Next morning I started to get electrical shock feelings on top of the tingling.  By Saturday I was in bed as my legs felt too weak to walk.  The tingling was mostly just in my legs at this point.  The electrical shock feeling was still coming and going but the tingling never stopped in my legs and feet.  It would wake me up out of a dead sleep.  This kept happening and I went to the doctor Monday morning.  I had started to improve some.  Still weak in my legs, tingling and some shock feelings.  The doctor felt it was a nerve response to the vaccine and would pass after a few more days.  It has improved as I am able to be up and doing things now.  Unfortunately the tingling hasn?t stop at all in my right legs.  Especially my last three toes and they hurt, burn and just feel odd most all the time.  I still get shock feelings at times in that foot and some times other places but not as often.  I still get tingling in the side of my head at times still also.  Now today 4/27/21 my right hand is hurting and hard to move.  My toes feel like they are curling under at times and they are perfectly straight.  I still have a few nights where the shock feeling with wake me up in the night.  Tomorrow will be two weeks from my vaccine.  I wondered if this has happened to others, when does it stop, and should I get the second vaccine?  I do not want to go back to the point where it was hard to walk even and the pain.
She had a pass out instance and She ended up being diagnosed with seizures; This is a spontaneous report from a contactable nurse This nurse (patient's mother) reported.  A 18-year-old female patient (reporter's daughter) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: unknown, Expiration date: unknown) via an unspecified route of administration on 03May2021 (age at vaccination 18-year-old) at DOSE 2 SINGLE for covid-19 immunisation. The patients medical history was not provided and concomitant medications were not reported. The patient previously took first dose of BNT62B2 (PFIZER-BIONTECH covid-19 vaccine, formulation: solution for injection, lot number: unknown) on an unspecified date in Apr2021 (age at vaccination 18-year-old) via an unspecified route of administration as DOSE 1 SINGLE for covid-19 immunization. Reporter stated, her daughter received the second Pfizer vaccine on the 03May2021 and she had a pass out instance and she ended up being diagnosed with a seizures on at the morning at the 08May2021 and they, we took her to the hospital. patient was in the Emergency Room on the morning of 08May. Reporter asked that was there any reaction that have occurred from Pfizer related to that. Because it was within 5 days of her receiving the vaccine and she has never had any instance like this in her life. patient received treatment with Keppra, 500mg, twice a day. The patient underwent lab tests and procedures which included test Investigation which was all fine on an unspecified date.The outcome of event was unknown.  Information about Lot/Batch number has been requested.; Sender's Comments: As there is limited information in the case provided, the causal association between the event and the suspect drug cannot be excluded. The case will be reassessed once new information is available.   The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities and Investigators, as appropriate.
Patient was given vaccine in right deltoid shortly after that lab tech started to draw blood on left arm. As tech was finishing drawing final tube patient fainted and than began to seize. Reaction could be a result of anxiety and not eating or drinking anything that morning.
arm sore really bad; Headache (pressure headache in forehead); Pain in the shoulder; stiff neck; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm sore really bad), HEADACHE (Headache (pressure headache in forehead)), ARTHRALGIA (Pain in the shoulder) and MUSCULOSKELETAL STIFFNESS (stiff neck) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm sore really bad), HEADACHE (Headache (pressure headache in forehead)), ARTHRALGIA (Pain in the shoulder) and MUSCULOSKELETAL STIFFNESS (stiff neck). On 02-Mar-2021, MUSCULOSKELETAL STIFFNESS (stiff neck) had resolved. At the time of the report, PAIN IN EXTREMITY (arm sore really bad), HEADACHE (Headache (pressure headache in forehead)) and ARTHRALGIA (Pain in the shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported .
Information has been received from a healthcare worker concerning multiple unspecified patients (demographics unknown). There was no medical history or drug reaction/allergies reported. Since 30-NOV-2015, the patient were vaccinated with ZOSTAVAX lot # L011533, expiration date- 03-JUL-2016 which were exposed to temperatures outside of the recommended range, (incorrect product storage). No adverse event was reported. The outcome of the event was unknown. This is one of the two cases received from the same reporter. Additional information has been requested.
This spontaneous report was received from a certified medical assistant (healthcare worker) refers to a patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 07-JAN-2016, the patient was vaccinated with an improperly stored VAQTA lot # L023232, 25-FEB-2017. This is one of the several reports received from the same reporter. Additional information has been requested.
Patient seen in clinic on 6-14 and admitted to observation in the hospital setting. Patient was transferred to Medical Center for higher level of care due to hypotension and elevated troponins on 6/15
Pt had fever, arm swelling (which are normal), but bruising at injection site that has not subsided even on 11/10 and swelling of glands in the armpit in the same arm as vaccination. No swelling in the other arm.
Information has been received from an office manager concerning one 5 year old girl and one 5 year old boy who were vaccinated with a dose of MMR II and VARIVAX (Merck) in one arm on an unspecified date.  Then the patients were vaccinated with a dose of IPOL and DTAP in the other arm on the same day.  After receiving MMR II and VARIVAX (Merck), the patient's arms were swollen, red and hot from their elbow all the way up to their shoulders.  There was no adverse reaction specified on the other arm.  The patients were given BENADRYL and CORTIZONE.  The reporter believed the patients had recovered since no information was heard from the patient's parents.  The patient sought unspecified medical attention.  This is one of several reports received from the same source.  Additional information has been requested.
Numbness and pain in feet, hands, around chest, pins and needles in arms, legs and face
No adverse effect reported; unknown doses of improperly stored GARDASIL 9 were administered; This spontaneous report as received from a nurse refers to a 12-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, concomitant medication, drug reactions and allergies was provided.  On 01-JUL-2019, the patient was vaccinated with improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) lot # R027577, expiration date 23-JUN-2021 (dose and route of administration were not provided) for prophylaxis. The vaccine was stored in the lowest registered temperature below 36 Fahrenheit degrees (30.60 F) for total 59 minutes and the highest registered temperature above 47 Fahrenheit degrees (49.10 F) for total 30 minutes. Previous temperature excursion was registered when the vaccine was stored in the temperature between 36 and 46 (45.5) Fahrenheit degrees for 1 hour. The digital data logger was involved.  No adverse effects were reported.; Sender's Comments:  US-009507513-1907USA012222: US-009507513-1907USA012231: US-009507513-1907USA012224: US-009507513-1907USA012225: US-009507513-1907USA012226: US-009507513-1907USA012227: US-009507513-1907USA012228: US-009507513-1907USA012229: US-009507513-1907USA002267: US-009507513-1907USA012221: US-009507513-1907USA012220: US-009507513-1907USA012219: US-009507513-1907USA012223:
Within 24 hours of booster dose of Moderna vaccine, noted severe joint pains which lasted about a day, and then worsening of profound, debilitating fatigue, worsening POTS, autonomic dysfunction symptoms--rapid heart rate, inability to stand for more than a few seconds, inability to walk longer than a few steps, temperature dysregulation (feeling too hot, night sweats); felt like a relapse of ME/CFS and POTS similar to the worsening of symptoms that occurred with mono infection--mostly bed bound, housebound. Still have not recovered to baseline before the vaccine.
Extreme fatigue, brain fog, constricted chest, chest pain for 4 days after my second dose. Now, I've been experiencing continued ongoing fatigue for 6 weeks. My legs grow heavy each day. I pass out from exhaustion early each night. I have trouble concentrating. I'm experiencing ankle and wrist pain with a feeling of low circulation as my feet and hands fall asleep if I sit too long. I'm also having vivid nightmares on an ongoing basis. Other than a back injury, I was healthy and normal before this vaccine. I have not been to a doctor. I have been resting, focused on eating well and taking 3000mg of Vit C a day.
Breakthrough case submission after 3 vaccines Pfizer 1/16/21 Lot# El3249;  Pfizer 2/3/21 Lot# El9265;  Pfizer 10/24/21 Lot# Ew0164;
Fever, muscle aches, tenderness at injection site, swelling of lymph nearest site of injection
Pt completed his 3rd dose of AVA on 01/17/2002 with no problem. On 02/03-02/03/2002, he noted a non pruritic follicular eruption on his forehead and scalp and has became mildly pruritic.
No adverse symptoms, signs, events administered expired dose on 10/31/12. Re-vaccinated per CDC recommendation on 12/1/12.
cancer after full Vx schedule; This serious case was reported by a pharmacist via call center representative and described the occurrence of cancer in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced cancer (Verbatim: cancer after full Vx schedule) (serious criteria GSK medically significant). The outcome of the cancer was unknown.   It was unknown if the reporter considered the cancer to be related to Shingrix.     It was unknown if the company considered the cancer to be related to Shingrix.   Additional Information: GSK Receipt Date: 10-APR-2023 The pharmacist mentioned that she had a patient who finished the full series of Shingrix (2 doses of Shingrix) in 2019, and after that patient started a cancer treatment.  The health care professional did not mentioned when the cancer started or was discovered.  The reporter permission for a follow-up was not asked during the interaction by phone with the pharmacist. The pharmacist called to ask about information of Shingrix and the number of doses approve by GSK.
This spontaneous report as received from a certified medical assistant refers to an unknown number of unspecified patients (ages unknown). Starting on or after 01-JUN-2016 the patients were vaccinated with GARDASIL 9 (lot # M004116, expiration date 12-OCT-2017) or with ROTATEQ (lot # L033545, expiration date 30-MAY-2017) that was improperly stored at 34 degrees F for 72 hours. No adverse events were reported. Additional information is not expected.
Info has been received from a registered nurse concerning a 73 year old female with severe asthma, allergies to tetanus and prochlorperazine (COMPAZINE) and no illness at the time of vaccination who on 10/15/2002 was vaccinated with a 2nd dose of pneumococcal vaccine 23 polyvalent (lot 64279/0111M) IM in the right deltoid. On 10/15/2002, the pt was concomitantly vaccinated with the 3rd dose of influenza virus vaccine (FLUZONE) (lot U0881AA). On 10/15/2002, the pt developed a reddened, swollen area 3 times size of silver dollar at the site of injection. The area was hot to the touch. The arm was extremely sore and difficult to move. Ice was applied and the pt was given acetaminophen (TYLENOL) for the pain. On 10/17/2002, the symptoms became worse. The pt was treated with methylprednisolone (MEDROL). The pt had a reaction to the methylprednisolone, and therapy with methylprednisolone was discontinued on 10/20/2002. The pt's symptoms were better and resolved on 10/21/2002. The nurse also reported that a pt developed cellulitis, flushing, pyrexia, headache, injection site erythema, injection site inflammation, movement disorder, and nausea (WAES #0210USA02344) and another pt developed injection site erythema and inflammation (WAES #0210USA02662) post vaccination with pneumococcal vaccine 23 polyvalent. No additional info is expected.
Covid 19 I tested positive for covid on July 18, 2022 I experienced scratchy throat, chills, fatigue, runny nose, body aches. I prescribed  Lagrevio for 5 days for my symptoms. I started to feel better after 2 days of taking medications and I still tested positive for 20 days after.
Nausea, denies chest pain, SOB, no difficulty swallowing. Initial BP 143/87 (pulse 64), 100% O2 sat. Final BP 133/89 (pulse 63), 100% O2 sat.
Shot: 10:00 am Moderna  Few Hours later felt slight head ache, joints sore, sleepy.  4-13--Woke 7:30 rash on left arm under injection site, across arm around 1-1/2" wide.  In bed all day flue symptoms, fever 99 which is high normal at 97.   4-14--Woke 7:30 rash is larger on arm spreading up to injection site.  Feeling better as far as all flue effects go , just more rash.
arm was red and sore the vaccine site was bigger than the palm of her hand, it was bruise, glands became swollen, joints swole, allergies became at all time high
pt recvd vax 20FEB96 9AM & 1030-11AM fever onset of 101.4 aural APAP given;slept restlessly for 1 1/2- 1 3/4hrs;about 245PM sudden onset of grand mal sz;taken to ER via amb where temp on admission was 103 aural;given ice baths x 2hrs;
Redness at injection site, worsened over next 4 days. Seen by urgent care, no treatment needed other than ice, seen by dermatologist, no treatment prescribed.
devel rash p/vax;taken to ER by mom;pt seen in evening for an allerg rxn (hives) to vax;
pt recv vax 8JUL97 & on 11JUL97 pt devel a temp of 102. This in follow-up to report(s) previously submitted on 10/16/1997; 1/16/1998. Information has been received from a health care professional concerning a 23 month old Caucasion male patient with no known allergies who on 08JUL97 was vaccinated with the first dose of VARIVAX SC in the right arm. On 11JUL97 the patient developed a "prolonged tempature of  102 F and no other sympptoms." On 15JUL97 the patient was diagnosed with a viral infection (eneterovirus). No further details were provided. This is an amended report: The patient's age now reads 23 months instead of 12 month and the narrative was updated accordingly. The county where administered and "vaccine administered by" have been added. This report is corrected as amended.
About 4 hours after the injection I started feeling nauseous and eventually started puking which continued for the rest of the night and into the next day. It was not until two days after the infection that I was able to hold down solid food again.
flare up of his glomerulonephritis kidney disease stage 4 and it had previously been diagnosed in 2013, then went into remission; The patient experienced a flare up of his vasculitis glomerulonephritis kidney disease stage 4 in the spring of 2021; The patient experienced a flare up of his vasculitis glomerulonephritis kidney disease stage 4 in the spring of 2021; The patient experienced a flare up of his vasculitis glomerulonephritis kidney disease stage 4 in the spring of 2021; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): 2022CCX00281.  A 68-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Vasculitis glomerulonephritis kidney disease stage 4", start date: 2013 (unspecified if ongoing), notes: it had previously been diagnosed in 2013 then went into remission; "Vasculitis glomerulonephritis kidney disease stage 4", start date: 2013 (unspecified if ongoing), notes: it had previously been diagnosed in 2013 then went into remission; "Vasculitis glomerulonephritis kidney disease stage 4", start date: 2013 (unspecified if ongoing), notes: it had previously been diagnosed in 2013 then went into remission. The patient's concomitant medications were not reported. The following information was reported: GLOMERULONEPHRITIS (medically significant), NEPHROPATHY (non-serious), VASCULITIS (non-serious) all with onset 2021, outcome "unknown" and all described as "The patient experienced a flare up of his vasculitis glomerulonephritis kidney disease stage 4 in the spring of 2021"; DISEASE RECURRENCE (non-serious), outcome "unknown", described as "flare up of his glomerulonephritis kidney disease stage 4 and it had previously been diagnosed in 2013, then went into remission".  Clinical course: On 08Aug2022, it was reported that a patient started treatment on an unspecified date with the Covid vaccine and boosters (Mfr. Pfizer) at unreported doses and frequencies of administration for vaccination. It was reported the patient experienced a flare up of his vasculitis glomerulonephritis kidney disease stage 4 in the spring of 2021 (it had previously been diagnosed in 2013, then went into remission). They (not further clarified) thought the Covid vaccine and boosters caused the flare up and that it really messed with his immune system. No further follow-up is anticipated.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.